1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > United States Histology and Cytology Market Outlook to 2021

United States Histology and Cytology Market Outlook to 2021

Summary

GlobalData’s new report, "United States Histology and Cytology Market Outlook to 2021", provides key market data on the United States Histology and Cytology market. The report provides value, in millions of US dollars within market segments - Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Histology and Cytology market includes Flow Cytometers, Monoclonal Antibodies, Polyclonal Antibodies, Tissue Typing Reagents and Immunmodulators.
- Annualized market revenues (USD million) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Histology and Cytology market.
- Global corporate-level profiles of key companies operating within the United States Histology and Cytology market.
- Key players covered include Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Danaher Corporation, Immucor, Inc., Thermo Fisher Scientific Inc., Abbott Laboratories and Sysmex Corporation.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table Of Contents

United States Histology and Cytology Market Outlook to 2021
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Histology and Cytology Market Segmentation 4
2.3 Definitions of Markets Covered in the Report 5
3 Histology and Cytology Market, United States 6
3.1 Histology and Cytology Market, United States, Revenue ($m), 2007-2014 6
3.2 Histology and Cytology Market, United States, Revenue ($m), 2014-2021 8
3.3 Histology and Cytology Market, United States, Distribution Share by Revenue ($m), 2013-2014 10
3.4 Histology and Cytology Market, United States, Company Share by Revenue ($m), 2014 11
4 Overview of Key Companies in United States, Histology and Cytology Market 13
4.1 Becton, Dickinson and Company 13
4.1.1 Company Overview 13
4.2 F. Hoffmann-La Roche Ltd. 13
4.2.1 Company Overview 13
4.3 Danaher Corporation 13
4.3.1 Company Overview 13
4.4 Immucor, Inc. 13
4.4.1 Company Overview 13
4.5 Thermo Fisher Scientific Inc. 14
4.5.1 Company Overview 14
4.6 Abbott Laboratories 14
4.6.1 Company Overview 14
4.7 Sysmex Corporation 14
4.7.1 Company Overview 14
5 Histology and Cytology Market Pipeline Products 15
6 Financial Deals Landscape 16
6.1 Acquisition 16
6.1.1 Vivione Biosciences Announces the Expiration of Agreement to Acquire Trillium Diagnostics for USD15 Million 16
7 Appendix 18
7.1 Research Methodology 19
7.1.1 Coverage 19
7.1.2 Secondary Research 19
7.1.3 Primary Research 19
7.1.4 Company Share Analysis 20
7.1.5 Distribution Share Analysis 20
7.2 GlobalData Consulting 20
7.3 Contact Us 20
7.4 Disclaimer 21

1.1 List of Tables
Table 1: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 7
Table 2: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 9
Table 3: Histology and Cytology Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014 10
Table 4: Histology and Cytology Market, United States, Company Share by Revenue ($m), USD Constant, 2014 12
Table 5: Histology and Cytology Market Pipeline Products 15
Table 6: Vivione Biosciences Announces the Expiration of Agreement to Acquire Trillium Diagnostics for USD15 Million 16

1.2 List of Figures
Figure 1: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014 6
Figure 2: Histology and Cytology Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021 8
Figure 3: Histology and Cytology Market, United States, Company Share (%) 2014 11

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Europe Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 36000
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 31-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

Cancer Diagnostics 2017-2021: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

  • $ 21100
  • Industry report
  • December 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. The report is available by country, section, market segment, and can be custom-tailored to your specific information ...

2017 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 Asia-Pacific Cancer Diagnostics Market: Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 11300
  • Industry report
  • February 2017
  • by Venture Planning Group

This new 17-country report from VPGMarketResearch.com is available by country, market segment, section, or individual test. This report is designed to assist diagnostics industry executives, as well as ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.